1. Home
  2. NGL vs HROW Comparison

NGL vs HROW Comparison

Compare NGL & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

N/A

Current Price

$15.43

Market Cap

2.0B

Sector

Utilities

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$30.75

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGL
HROW
Founded
1940
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
NGL
HROW
Price
$15.43
$30.75
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $65.00
AVG Volume (30 Days)
149.9K
★ 486.5K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.43
EPS
★ N/A
N/A
Revenue
★ $3,156,159,000.00
N/A
Revenue This Year
$5.18
$28.81
Revenue Next Year
N/A
$53.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.88
$28.54
52 Week High
$19.06
$54.98

Technical Indicators

Market Signals
Indicator
NGL
HROW
Relative Strength Index (RSI) 30.96 27.10
Support Level $14.26 $28.54
Resistance Level $16.70 $35.43
Average True Range (ATR) 0.55 1.25
MACD -0.23 -0.21
Stochastic Oscillator 10.03 11.48

Price Performance

Historical Comparison
NGL
HROW

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: